Mucosal Immunity and Vaccines

There is currently great interest in developing mucosal vaccines against a variety of microbial pathogens. Mucosally induced tolerance also seems to be a promising form of immunomodulation for treating certain autoimmune diseases and allergies. Mucosal tissues (e.g. nasal, oral, ocular, rectal, vaginal) cover a large surface of the body. Since many infections are initiated at mucosal sites, it is critical to develop strategies for neutralising the infectious agent at these surfaces.

    Related Conference of Mucosal Immunity and Vaccines

    May 05-06, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Rome, Italy
    May 19-20, 2025

    3rd World Congress on Infectious and Contagious Disease

    Rome, Italy
    May 22-23, 2025

    6th International Conference on Immunology and Radiotherapy

    Toronto, Canada
    June 23-24, 2025

    19th International Conference on European Immunology

    Paris, France
    July 24-25, 2025

    20th International Conference on Allergic Diseases and Clinical Immunology

    Paris, France
    August 18-19, 2025

    13th International Conference on Cancer & Tumor Immunology

    Rome, Italy
    August 26-27, 2025

    6th International conference on Vaccines, Vaccination and Immunization

    Paris, France
    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands

    Mucosal Immunity and Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in